Legend Biotech Corp (LEGN) Total Debt (2021 - 2024)
Legend Biotech (LEGN) has disclosed Total Debt for 4 consecutive years, with $301.2 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Total Debt rose 7.06% year-over-year to $301.2 million, compared with a TTM value of $301.2 million through Dec 2024, up 7.06%, and an annual FY2024 reading of $301.2 million, up 7.06% over the prior year.
- Total Debt was $301.2 million for Q4 2024 at Legend Biotech, up from $281.3 million in the prior quarter.
- Across five years, Total Debt topped out at $301.2 million in Q4 2024 and bottomed at $120.5 million in Q4 2021.
- Average Total Debt over 4 years is $241.0 million, with a median of $271.1 million recorded in 2022.
- The sharpest move saw Total Debt soared 116.61% in 2022, then rose 7.06% in 2024.
- Year by year, Total Debt stood at $120.5 million in 2021, then skyrocketed by 116.61% to $260.9 million in 2022, then increased by 7.82% to $281.3 million in 2023, then increased by 7.06% to $301.2 million in 2024.
- Business Quant data shows Total Debt for LEGN at $301.2 million in Q4 2024, $281.3 million in Q4 2023, and $260.9 million in Q4 2022.